Tallac Therapeutics
Edit

Tallac Therapeutics

https://www.tallactherapeutics.com/
Last activity: 03.08.2023
Tags:BioTechDevelopmentPlatformResearch
Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.
Mentions
7
Location: United States, California, Burlingame
Employees: 11-50
Total raised: $77M
Founded date: 2018

Investors 2

Funding Rounds 2

DateSeriesAmountInvestors
03.08.2023-$15M-
01.12.2020Series A$62MMatrix Par...

Mentions in press and media 7

DateTitleDescriptionSource
03.08.2023Tallac Therapeutics Receives $15M Venture Loan FacilityTallac Therapeutics, Inc., a Burlingame, CA-based developer of multiple novel immunotherapies to fig...finsmes.co...
02.12.2020Tallac raises $62M in Series A to advance novel cancer immun...-vcbay.news...
02.12.2020Daily funding roundup - Dec. 1st, 2020WaveOne has raised $6.5M; Databand landed $14.5M; Proscia has secured $23M Reposite: Reposite is a ...vator.tv/n...
01.12.2020Tallac Therapeutics launches with $62M run by ALX Oncology v...A host of top-suite venture capitalist firms has helped put together a meaty series A for an immuno-...fiercebiot...
01.12.2020Tallac Therapeutics Raises $62M in Series A FinancingTallac Therapeutics, Inc., a Burlingame, Calif.-based biopharmaceutical company harnessing the power...finsmes.co...
01.12.2020Tallac Therapeutics launches with $62M run by ALX Oncology v...A host of top-suite venture capitalist firms has helped put together a meaty series A for an immuno-...fiercebiot...
-Tallac Therapeutics“Tallac Therapeutics, Inc – Landing page”fastfounde...